Applicant, as named in the Orange Book
Fidelity Biopharma
Next listed expiry: Ontralfy on 7 May 2042. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Ontralfy NDA 216190 tizanidine hydrochloride | 7 May 2042 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.